CXCR4 and neoplasm: The use of CXCR4 antagonist has the role of unmasking the tumor to immune attack by multiple mechanisms, such as decreasing the infiltration of MDSCs, increasing the ratio of CD8+ T cells to Treg cells and eliminating tumor revascularization.